← Back to headlines
Matinas BioPharma Receives Notice from NYSE
Matinas BioPharma has announced that it received a notice from the New York Stock Exchange regarding a compliance matter.
3 Apr, 21:20 — 3 Apr, 21:20
Sources
Showing 1 of 1 sources
Matinas BioPharma has announced that it received a notice from the New York Stock Exchange regarding a compliance matter.